ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NATCOPHARM NEWS why is Natco Pharma Limited price falling or rising

NATCOPHARM NEWS reasons for why stock price of Natco Pharma Limited is falling or rising

NATCOPHARM Natco Pharma is falling or rising technical reasons

Technical analysis forecast of Natco Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Natco Pharma NATCOPHARM at this time. Stock is rising and might rise more.

It appears as if Natco Pharma NATCOPHARM gave a large move recently.

Stock of Natco Pharma (NATCOPHARM) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Natco Pharma is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Natco Pharma stays above 930.3, but if it comes below 930.3, then a intra day sell could be more profitable.
If you take a sell trade below 930.3, then use 930.3 as stoploss and 880.32 as target. However if you take a buy trade in Natco Pharma, then use 930.3 as stoploss and 990.3 as target.

NATCOPHARM Natco Pharma is falling or rising NEWS fundamental reasons

Company Announcement Natco Pharma Limited has informed the Exchange regarding Appointment of Mr AMIT PAREKH as Other of the company w.e.f. December 02, 2025. - NEWS as on 2025-12-02

Company Announcement Natco Pharma Limited has informed the Exchange about Credit Rating - NEWS as on 2025-12-01

Natco Pharma shares drop over 5% after previous day’s double-digit gains Natco Pharma shares fell as investors booked profits after a sharp rally in the previous session. The stock has been volatile this week, slipping earlier after the US FDA issued seven Form-483 observations at its Manali API plant, which the company said we - NEWS as on 2025-11-27 indiatimes.com

Natco Pharma shares jump over 5% after three-day slump Natco Pharma shares surged on Wednesday, bouncing back from a three-day decline that followed a US FDA inspection of its API manufacturing facility in Manali, Chennai, conducted from November 17–21, 2025. The inspection flagged seven Form-483 observations, - NEWS as on 2025-11-26 indiatimes.com

Company Announcement Natco Pharma Limited has informed the Exchange about Transcript - NEWS as on 2025-11-21

Company Announcement Natco Pharma Limited has informed the Exchange about Link of Recording - NEWS as on 2025-11-17

Company Announcement Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Adcock Ingram Holdings Limited completes delisting from Johannesburg Stock Exchange and NATCO Pharma Limited acquires 35.75% stake". - NEWS as on 2025-11-12

Company Announcement Natco Pharma Limited has informed the Exchange about Revised intimation earnings call for the quarter and half year ended 30th September, 2025 - NEWS as on 2025-11-11

Company Announcement - NEWS as on 2025-11-07

Company Announcement Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)". - NEWS as on 2025-10-31

Company Announcement Natco Pharma Limited has informed the Exchange regarding a press release dated October 17, 2025, titled "Legal update regarding Risdiplam ". - NEWS as on 2025-10-20

Company Announcement Natco Pharma Limited has informed the Exchange regarding a press release dated October 09, 2025, titled "Legal update regarding Risdiplam Commercial Appellate Division of the Hon ble Delhi High Court Dismissed Appeal ". - NEWS as on 2025-10-10

More announcements and NEWS

NATCOPHARM Natco Pharma Limited current price & indicator signals

Moving Averages for Natco Pharma Limited

  • 5Day Average: 930.8
  • 12Day Average: 895.9
  • 20Day Average: 863.46
  • 50Day Average: 838.82
  • 100Day Average: 874.93
  • 150Day Average: 878.74
  • 200Day Average: 864.67

NATCOPHARM Indicators & signals

Indicator MACD (12,26,9)

900.11, 871.44, 18.73
Indicator MACD is in positive zone

Indicator ADX (14)

42.86, 30.13, 12.05
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NATCOPHARM Natco Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 933.60 928.20 to 945.95 -1.65% 0.18 times
04 Thu Dec 2025 949.25 910.50 to 950.10 1.48% 0.48 times
03 Wed Dec 2025 935.40 924.05 to 943.90 0.31% 0.43 times
02 Tue Dec 2025 932.55 897.40 to 948.80 3.25% 1.82 times
01 Mon Dec 2025 903.20 880.00 to 923.00 2.96% 1.11 times
28 Fri Nov 2025 877.25 869.25 to 900.90 -0.62% 0.45 times
27 Thu Nov 2025 882.75 876.00 to 934.50 -4.81% 1.15 times
26 Wed Nov 2025 927.40 834.00 to 938.15 11.2% 4.11 times
25 Tue Nov 2025 834.00 826.95 to 850.95 -0.86% 0.1 times
24 Mon Nov 2025 841.25 837.35 to 864.10 -2.72% 0.21 times
21 Fri Nov 2025 864.80 857.00 to 872.90 -0.52% 0.15 times
20 Thu Nov 2025 869.30 828.30 to 887.65 4.72% 1.63 times

Videos related to: NATCOPHARM NEWS why is Natco Pharma Limited price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

NATCOPHARM NEWS why is Natco Pharma Limited price falling or rising

 

Back to top